Baker-Bros-Advisors-Lp

AI_NATIVE detailed information: This accession holds the following tickers:[
  "MRUS",
  "AKRO",
  "KNSA",
  "EWTX",
  "CNTA",
  "ALKS",
  "INSM",
  "RVMD",
  "ARGX",
  "ACAD",
  "MDGL",
  "ABCL",
  "PRME",
  "SKYE",
  "TCRX",
  "RCKT",
  "BCAX",
  "BCYC",
  "GPCR",
  "IMTX",
  "RLAY",
  "IGMS",
  "TSHA",
  "TYRA",
  "NRIX",
  "STOK",
  "ACRV",
  "SMMT",
  "TECX",
  "KYMR",
  "REPL",
  "NMRA",
  "GLUE",
  "NGNE",
  "TSVT",
  "ALMS",
  "ALGS",
  "CTNM",
  null,
  "FATE",
  "SANA",
  null,
  "KALA",
  "LPTX",
  "PRLD",
  "SGMT",
  "IONS",
  "TARA",
  null,
  "IDYA",
  "INCY",
  "SERA",
  "PRAX",
  "RGLS",
  "RYTM",
  "NTLA",
  "DYN",
  null,
  "GRAL",
  "WVE",
  "ROIV",
  "OPT",
  "ELVN",
  "GBIO",
  "IMCR",
  "HOOK",
  "DSGN",
  "KOD",
  "VRNA",
  "VERV",
  "VIR",
  "VTVT",
  "XENE",
  "TRDA",
  "XNCR",
  "RARE",
  "IMVT",
  "PCVX",
  null,
  "BNTX",
  "CADL",
  "CELC",
  "CLDX",
  "CERS",
  "IPSC",
  "CMPX",
  "CRSP",
  "DNLI",
  "IRON"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 89
Total Value: 9036702464
Accession Number: 0001104659-25-049518
Form Type: 13F-HR
CIK: baker-bros-advisors-lp
Manager Name: Baker-Bros-Advisors-Lp

Data Enrichment

94% identified

84 identified5 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

89 positions • $9.0B total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 2 of 5

Sort by:

Kodiak Sciences Inc.

KOD|50015M109

Shares:17.3M

Value:$48.6M

% of Portfolio:0.5% ($48.6M/$9.0B)

Nurix Therapeutics, Inc.

NRIX|67080M103

Shares:3.9M

Value:$46.1M

% of Portfolio:0.5% ($46.1M/$9.0B)

ARGENX SE

ARGX|04016X101

Shares:77.8K

Value:$46.0M

% of Portfolio:0.5% ($46.0M/$9.0B)

Entrada Therapeutics, Inc.

TRDA|29384C108

Shares:4.9M

Value:$44.0M

% of Portfolio:0.5% ($44.0M/$9.0B)

Celcuity Inc.

CELC|15102K100

Shares:4.3M

Value:$43.0M

% of Portfolio:0.5% ($43.0M/$9.0B)

GRAIL, Inc.

GRAL|384747101

Shares:1.6M

Value:$41.6M

% of Portfolio:0.5% ($41.6M/$9.0B)

Roivant Sciences Ltd.

ROIV|G76279101

Shares:3.8M

Value:$38.0M

% of Portfolio:0.4% ($38.0M/$9.0B)

Immatics N.V.

IMTX|N44445109

Shares:7.3M

Value:$32.8M

% of Portfolio:0.4% ($32.8M/$9.0B)

Stoke Therapeutics, Inc.

STOK|86150R107

Shares:4.6M

Value:$30.8M

% of Portfolio:0.3% ($30.8M/$9.0B)

CERUS CORP

CERS|157085101

Shares:19.4M

Value:$26.9M

% of Portfolio:0.3% ($26.9M/$9.0B)

Vaxcyte, Inc.

PCVX|92243G108

Shares:640.9K

Value:$24.2M

% of Portfolio:0.3% ($24.2M/$9.0B)

Monte Rosa Therapeutics, Inc.

GLUE|61225M102

Shares:4.9M

Value:$22.8M

% of Portfolio:0.3% ($22.8M/$9.0B)

CRISPR Therapeutics AG

CRSP|H17182108

Shares:654.1K

Value:$22.3M

% of Portfolio:0.2% ($22.3M/$9.0B)

Akero Therapeutics, Inc.

AKRO|00973Y108

Shares:548.7K

Value:$22.2M

% of Portfolio:0.2% ($22.2M/$9.0B)

SERA PROGNOSTICS, INC.

SERA|81749D107

Shares:5.5M

Value:$20.2M

% of Portfolio:0.2% ($20.2M/$9.0B)

Centessa Pharmaceuticals plc

CNTA|152309100

Shares:1.2M

Value:$17.6M

% of Portfolio:0.2% ($17.6M/$9.0B)

Neurogene Inc.

NGNE|64135M105

Shares:1.5M

Value:$17.4M

% of Portfolio:0.2% ($17.4M/$9.0B)

IDEAYA Biosciences, Inc.

IDYA|45166A102

Shares:1.1M

Value:$17.4M

% of Portfolio:0.2% ($17.4M/$9.0B)

Verona Pharma plc

VRNA|925050106

Shares:223.8K

Value:$14.2M

% of Portfolio:0.2% ($14.2M/$9.0B)

Candel Therapeutics, Inc.

CADL|137404109

Shares:2.4M

Value:$13.8M

% of Portfolio:0.2% ($13.8M/$9.0B)

Instrument	Shares		Other Manager	Value	% of Portfolio
Kodiak Sciences Inc.(KODcusip50015M109)	17.3M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$48.6M	0.5% ($48.6M/$9.0B)	QoQ -71.80% (-$123.7M) YoY -46.67% (-$42.5M)
Nurix Therapeutics, Inc.(NRIXcusip67080M103)	3.9M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$46.1M	0.5% ($46.1M/$9.0B)	QoQ -36.94% (-$27.0M) YoY -19.18% (-$10.9M)
ARGENX SE(ARGXcusip04016X101)	77.8K	QoQ -30.51% (-34.1K) YoY -48.57% (-73.5K)	All Managers (Combined)	$46.0M	0.5% ($46.0M/$9.0B)	QoQ -33.12% (-$22.8M) YoY -22.69% (-$13.5M)
Entrada Therapeutics, Inc.(TRDAcusip29384C108)	4.9M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$44.0M	0.5% ($44.0M/$9.0B)	QoQ -47.71% (-$40.1M) YoY -36.20% (-$25.0M)
Celcuity Inc.(CELCcusip15102K100)	4.3M	QoQ +58.95% (+1.6M) YoY +174.25% (+2.7M)	All Managers (Combined)	$43.0M	0.5% ($43.0M/$9.0B)	QoQ +22.76% (+$8.0M) YoY +28.36% (+$9.5M)
GRAIL, Inc.(GRALcusip384747101)	1.6M	QoQ 0.00% (+0) YoY NEW(+1.6M)	All Managers (Combined)	$41.6M	0.5% ($41.6M/$9.0B)	QoQ +43.08% (+$12.5M) YoY NEW(+$41.6M)
Roivant Sciences Ltd.(ROIVcusipG76279101)	3.8M	QoQ 0.00% (-0) YoY -49.17% (-3.6M)	All Managers (Combined)	$38.0M	0.4% ($38.0M/$9.0B)	QoQ -14.70% (-$6.6M) YoY -51.34% (-$40.1M)
Immatics N.V.(IMTXcusipN44445109)	7.3M	QoQ 0.00% (-0) YoY +12.91% (-832.4K)	All Managers (Combined)	$32.8M	0.4% ($32.8M/$9.0B)	QoQ -36.56% (-$18.9M) YoY -51.54% (-$34.9M)
Stoke Therapeutics, Inc.(STOKcusip86150R107)	4.6M	QoQ 0.00% (-0) YoY +37.56% (-1.3M)	All Managers (Combined)	$30.8M	0.3% ($30.8M/$9.0B)	QoQ -39.70% (-$20.3M) YoY -32.23% (-$14.7M)
CERUS CORP(CERScusip157085101)	19.4M	QoQ -0.64% (-126.3K) YoY -0.64% (-126.3K)	All Managers (Combined)	$26.9M	0.3% ($26.9M/$9.0B)	QoQ -10.32% (-$3.1M) YoY -26.93% (-$9.9M)
Vaxcyte, Inc.(PCVXcusip92243G108)	640.9K	QoQ +1211.00% (+592.0K) YoY +1211.00% (+592.0K)	All Managers (Combined)	$24.2M	0.3% ($24.2M/$9.0B)	QoQ +504.73% (+$20.2M) YoY +624.68% (+$20.9M)
Monte Rosa Therapeutics, Inc.(GLUEcusip61225M102)	4.9M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$22.8M	0.3% ($22.8M/$9.0B)	QoQ -33.14% (-$11.3M) YoY -34.18% (-$11.8M)
CRISPR Therapeutics AG(CRSPcusipH17182108)	654.1K	QoQ -49.99% (-653.9K) YoY NEW(+654.1K)	All Managers (Combined)	$22.3M	0.2% ($22.3M/$9.0B)	QoQ -56.76% (-$29.2M) YoY NEW(+$22.3M)
Akero Therapeutics, Inc.(AKROcusip00973Y108)	548.7K	QoQ -49.98% (-548.4K) YoY -79.77% (-2.2M)	All Managers (Combined)	$22.2M	0.2% ($22.2M/$9.0B)	QoQ -27.22% (-$8.3M) YoY -67.59% (-$46.3M)
SERA PROGNOSTICS, INC.(SERAcusip81749D107)	5.5M	QoQ +1.17% (-63.8K) YoY +1.17% (-63.8K)	All Managers (Combined)	$20.2M	0.2% ($20.2M/$9.0B)	QoQ -54.26% (-$24.0M) YoY -59.08% (-$29.2M)
Centessa Pharmaceuticals plc(CNTAcusip152309100)	1.2M	QoQ 0.00% (-0) YoY NEW(+1.2M)	All Managers (Combined)	$17.6M	0.2% ($17.6M/$9.0B)	QoQ -14.14% (-$2.9M) YoY NEW(+$17.6M)
Neurogene Inc.(NGNEcusip64135M105)	1.5M	QoQ +120.35% (+811.8K) YoY +225.91% (-1.0M)	All Managers (Combined)	$17.4M	0.2% ($17.4M/$9.0B)	QoQ +12.87% (+$2.0M) YoY -25.02% (-$5.8M)
IDEAYA Biosciences, Inc.(IDYAcusip45166A102)	1.1M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$17.4M	0.2% ($17.4M/$9.0B)	QoQ -36.26% (-$9.9M) YoY -62.67% (-$29.2M)
Verona Pharma plc(VRNAcusip925050106)	223.8K	QoQ NEW(+223.8K) YoY NEW(+223.8K)	All Managers (Combined)	$14.2M	0.2% ($14.2M/$9.0B)	QoQ NEW(+$14.2M) YoY NEW(+$14.2M)
Candel Therapeutics, Inc.(CADLcusip137404109)	2.4M	QoQ -18.26% (-544.8K) YoY NEW(+2.4M)	All Managers (Combined)	$13.8M	0.2% ($13.8M/$9.0B)	QoQ -46.79% (-$12.1M) YoY NEW(+$13.8M)